Middle East and Africa Iodinated Contrast Media in Interventional X-Ray Market – Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Published Report
  • Dec 2019
  • MEA
  • 350 Pages
  • No of Tables: 77
  • No of Figures: 41

Middle East and Africa Iodinated Contrast Media in Interventional X-Ray Market By Route of Administration (Intravenous, Oral, Rectal, Others), Indication (Cardiology, Neurology, General Surgery, Oncology, Urology), Agent Type (Non-Ionic, Ionic), End User (Hospital, Specialty Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research & Academic Institutes), By Country (UAE, Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa)) Market Trends and Forecast to 2027

Market Analysis and Insights : Middle East and Africa Iodinated Contrast Media in Interventional X-Ray Market

Iodinated contrast media in interventional X-ray market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with an excellent CAGR of 3.1% in the forecast period of 2020 to 2027and expected to reach USD 4,202.26 million by 2027 from USD 3,286.50 million in 2019. Growing awareness related to contrast imaging agents and unmet demand for interventional diagnosis procedures rising are the factors for the market growth.  

Iodinated contrast media in interventional X-ray is witnessing prominent growth as demand of clinical and diagnostic across various levels of health care services for variety of indication. Furthermore, increasing demand healthcare expenditure to perform the interventional diagnosis tests is augmenting the market growth. Strategic government reforms are also leading to high adoption of interventional surgeries which further boom the growth of the diagnosis market.

This iodinated contrast media in interventional X-ray market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Middle East and Africa Iodinated Contrast Media in Interventional X-Ray Market Scope and Market Size

Middle East and Africa iodinated contrast media in interventional X-ray market is segmented of the basis of route of administration, indication, agent type and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Based on route of administration, iodinated contrast media in interventional X-ray market is segmented into oral, intravenous, rectal, others. Intravenous segment is dominating the market because it is widely accepted route of administration across the region.

Based on agent type, iodinated contrast media in interventional X-ray market is segmented into ionic and non-ionic. Non-ionic segment is dominating the market because these agents mostly are used in diagnostic procedures for numerous diseases and are far less expensive.

Based on indication, iodinated contrast media in interventional X-ray market is segmented into cardiology, oncology, urology, general surgery and neurology. Cardiology segment is dominating the market due to rising number of chronic disease and growing popularity of iodinated agents for improved diagnosis.

Based on end user, the market is segmented into hospital, specialty clinics, diagnostic centers, ambulatory surgical centres, research & academic institutes. Hospital segment is dominating the market throughout the forecast period due to high volume of interventional radiology diagnostic procedure performed in hospital. Whereas, the lack of private imaging centers will shift the patient pool towards hospital segment as these facilities are well equipped for interventional radiology diagnostic procedure.

Iodinated Contrast Media in Interventional X-Ray Market Country Level Analysis

Middle East and Africa iodinated contrast media in interventional X-ray market is analysed and market size information is provided by country, route of administration, agent type, indication, and end user as referenced above. Middle East and Africa is growing with an increasing number of the chronic diseases and increasing healthcare expenditure.  

The countries covered in the iodinated contrast media in interventional X-ray market report are UAE, Saudi Arabia, Egypt, Israel, South Africa and Rest of Middle East and Africa.

UAE dominates the Middle East and Africa iodinated contrast media in interventional X-ray market due to strong healthcare infrastructure base as well as increased consumption of iodinated contrast media in interventional X-ray.

The country section of iodinated contrast media in interventional X-ray market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Increasing Awareness about Diagnosis and Treatment of the Disease is to Boost Iodinated Contrast Media in Interventional X-Ray

Middle East and Africa iodinated contrast media in interventional X-ray market also provides you with detailed market analysis for every country growth in medical industry with iodinated contrast media in interventional X-ray sales, components sales, impact of technological development in laboratories and changes in regulatory scenarios with their support for the iodinated contrast media in interventional X-ray market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Iodinated Contrast Media in Interventional X-Ray Market Share Analysis

Middle East and Africa iodinated contrast media in interventional X-ray market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East and Africa presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, concept cars, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Middle East and Africa iodinated contrast media in interventional X-ray market.

The major players covered in the report are Bayer AG, Iso-Tex Diagnostics, Inc., Bracco Diagnostic Inc., Novalek Pharmaceuticals Pvt. Ltd., iMAX, Taejoon Pharm, Unijules Life Sciences Ltd, General Electric, Guerbet LLC, J.B.Chemicals & Pharmaceuticals Ltd among others players domestic and global. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

For instance,

  • In June 2019, General Electric and Daiichi Sankyo Company did an agreement that Daiichi Sankyo to transfer authorization of marketing rights for four diagnostic imaging agents in Japan to GE Healthcare. After completing this agreement the company expand their diagnostic imaging agents in the Japan. This will help company to expand their business in the market.
  • In July 2018, General Electric announced that they have launched ready-to-drink oral solution of iodinated contrast agent which can help physicians improving the visualization of diagnostic abdominal gastrointestinal tract. With this new formulation of contrast agent the company enhanced its choice of options for oral contrast agent which is available to radiologists and patients.

Customization Available : Middle East and Africa Iodinated Contrast Media in Interventional X-Ray Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), product under development data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 LIST OF FDA APPROVED NON-IONIC IODINATED AGENTS

TABLE 2 LIST OF FDA APPROVED IONIC IODINATED AGENTS

TABLE 3 COST OF CONTRAST MEDIA

TABLE 4 LIST OF UPCOMING GENERIC CONTRAST MEDIA AGENTS

TABLE 5 DOSAGE OF CONTRAS MEDIA TO BE TAKEN AS PER PATIENT’S WEIGHT

TABLE 6 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA INTRAVENOUS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA ORAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA RECTAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA OTHERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA HOSPITAL IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA DIAGNOSTIC CENTERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA AMBULATORY SURGICAL CENTERS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA RESEARCH & ACADEMIC INSTITUTES IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA NEUROLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA GENERAL SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA ONCOLOGY SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA UROLOGY SURGERY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITER)

TABLE 27 MIDDLE EAST AND AFRICA NON-IONIC IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA IONIC IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 37 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 38 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 39 U.A.E. CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 40 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 41 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 42 U.A.E. SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 43 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 44 U.A.E. IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 45 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 46 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 47 SAUDI ARABIA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 48 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 49 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 50 SAUDI ARABIA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 51 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 52 SAUDI ARABIA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 53 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 54 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 55 EGYPT CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 56 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 57 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 58 EGYPT SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 59 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 60 EGYPT IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 61 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 62 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 63 SOUTH AFRICA CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 64 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 65 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 66 SOUTH AFRICA SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 67 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 68 SOUTH AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 69 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

TABLE 70 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY INDICATION, 2018-2027 (USD MILLION)

TABLE 71 ISRAEL CARDIOLOGY IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY INDICATION, 2018-2027 (USD MILLION)

TABLE 72 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (USD MILLION)

TABLE 73 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY END USER, 2018-2027 (USD MILLION)

TABLE 74 ISRAEL SPECIALTY CLINICS IN IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 75 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (VOLUME IN LITRE)

TABLE 76 ISRAEL IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET,  BY AGENT TYPE, 2018-2027 (PRICE PER LITRE (USD))

TABLE 77 REST OF MIDDLE EAST & AFRICA IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions